Key statistics
On Monday, Edgewise Therapeutics Inc (EWTX:NSQ) closed at 27.61, -7.97% below its 52-week high of 30.00, set on Sep 19, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 27.59 |
---|---|
High | 28.02 |
Low | 26.80 |
Bid | 26.00 |
Offer | 29.72 |
Previous close | 28.40 |
Average volume | 1.02m |
---|---|
Shares outstanding | 93.77m |
Free float | 93.33m |
P/E (TTM) | -- |
Market cap | 2.66bn USD |
EPS (TTM) | -1.53 USD |
Data delayed at least 15 minutes, as of Oct 07 2024 21:00 BST.
More ▼
Press releases
- Edgewise Therapeutics to Present on Sevasemten (EDG-5506) for Becker Muscular Dystrophy (Becker) at the 29th International Annual Congress of the World Muscle Society
- Edgewise Therapeutics Announces Positive Top-Line Data from Phase 1 Trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM)
- Edgewise Therapeutics to Host Webcast Event to Discuss Top-Line Data from Phase 1 trial in Healthy Subjects and Phase 2 CIRRUS-HCM Trial in Patients with Obstructive Hypertrophic Cardiomyopathy (HCM) on Thursday, September 19 at 8:30 am Eastern Time
- Edgewise Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights